ADVANCE ONLINE PUBLICATION
The latest research papers, published online ahead of print. These online versions are definitive and may be cited using the digital object identifier (DOI).
About advance online publication
November 12 2009 |
November 5 2009 |
October 29 2009 |
October 22 2009 |
October 15 2009 |
October 8 2009 |
October 1 2009 |
September 24 2009 |
September 17 2009 |
September 10 2009 |
September 3 2009 |
August 27 2009 |
August 13 2009 |
August 6 2009
November 19 2009
Original Articles
Heat stress triggers apoptosis by impairing NF-
B survival signaling in malignant B cells
G Belardo, R Piva and M G Santoro
Leukemia advance online publication, November 19, 2009; doi:10.1038/leu.2009.227
Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR–ABL cleavage and elimination of chronic myelogenous leukemia cells
A Puissant, P Colosetti, G Robert, J-P Cassuto, S Raynaud and P Auberger
Leukemia advance online publication, November 19, 2009; doi:10.1038/leu.2009.233
Diverging effects of HLA–DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles
B E Shaw, N P Mayor, N H Russell, J F Apperley, R E Clark, J Cornish, P Darbyshire, M E Ethell, J M Goldman, A-M Little, S Mackinnon, D I Marks, A Pagliuca, K Thomson, S G E Marsh and J A Madrigal
Leukemia advance online publication, November 19, 2009; doi:10.1038/leu.2009.239
Letter to the Editor
Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity
B Gerby, F Armstrong, P B de la Grange, H Medyouf, J Calvo, E Verhoeyen, F L Cosset, I Bernstein, S Amselem, N Boissel, H Dombret, T Leblanc, A Baruchel, J Landman-Parker, P Ballerini and F Pflumio
Leukemia advance online publication, November 19, 2009; doi:10.1038/leu.2009.235
November 12 2009
Review
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
H Quach, D Ritchie, A K Stewart, P Neeson, S Harrison, M J Smyth and H M Prince
Leukemia advance online publication, November 12, 2009; doi:10.1038/leu.2009.236
Original Articles
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4
M Bardini, R Spinelli, S Bungaro, E Mangano, L Corral, I Cifola, G Fazio, M Giordan, G Basso, G De Rossi, A Biondi, C Battaglia and G Cazzaniga
Leukemia advance online publication, November 12, 2009; doi:10.1038/leu.2009.203
Recruitment of PKC-
II to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70
C Meyer zum Büschenfelde, M Wagner, G Lutzny, M Oelsner, Y Feuerstacke, T Decker, C Bogner, C Peschel and I Ringshausen
Leukemia advance online publication, November 12, 2009; doi:10.1038/leu.2009.216
Letters to the Editor
A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma
E Chanudet, Y Huang, K Ichimura, G Dong, R A Hamoudi, J Radford, A C Wotherspoon, P G Isaacson, J Ferry and M-Q Du
Leukemia advance online publication, November 12, 2009; doi:10.1038/leu.2009.234
Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia
E Chapiro, L Russell, E Lainey, S Kaltenbach, C Ragu, V Della-Valle, K Hanssens, E A Macintyre, I Radford-Weiss, E Delabesse, H Cavé, T Mercher, C J Harrison, F Nguyen-Khac, P Dubreuil and O A Bernard
Leukemia advance online publication, November 12, 2009; doi:10.1038/leu.2009.231
November 5 2009
Meeting Report
The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6–7 May 2009
A Biondi, A Baruchel, S Hunger, G Masera, K Schmiegelow, M Schrappe and C H Pui
Leukemia advance online publication, November 5, 2009; doi:10.1038/leu.2009.211
Original Articles
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
N Gefen, V Binder, M Zaliova, Y Linka, M Morrow, A Novosel, L Edry, L Hertzberg, N Shomron, O Williams, J Trka, A Borkhardt and S Izraeli
Leukemia advance online publication, November 5, 2009; doi:10.1038/leu.2009.208
WAVE1 regulates Bcl-2 localization and phosphorylation in leukemia cells
R Kang, D Tang, Y Yu, Z Wang, T Hu, H Wang and L Cao
Leukemia advance online publication, November 5, 2009; doi:10.1038/leu.2009.224
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells
U Rix, L L Remsing Rix, A S Terker, N V Fernbach, O Hantschel, M Planyavsky, F P Breitwieser, H Herrmann, J Colinge, K L Bennett, M Augustin, J H Till, M C Heinrich, P Valent and G Superti-Furga
Leukemia advance online publication, November 5, 2009; doi:10.1038/leu.2009.228
TNF-
-converting enzyme (TACE/ADAM17)-dependent loss of CD30 induced by proteasome inhibition through reactive oxygen species
A M Vahdat, K S Reiners, V L Simhadri, D A Eichenauer, B Böll, A Chalaris, V R Simhadri, K Wiegmann, H-W Krell, S Rose-John, A Engert, E P von Strandmann and H P Hansen
Leukemia advance online publication, November 5, 2009; doi:10.1038/leu.2009.230
Letter to the Editor
Measuring the prognostic impact of ferritin levels in myelodysplastic syndrome patients: the role of susceptibility biases
A Jerez, A Fernández, M M Osma, V Roldán, F J Ortuño and V Vicente
Leukemia advance online publication, November 5, 2009; doi:10.1038/leu.2009.229
October 29 2009
Spotlight Review
Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways
W-L Zhao
Leukemia advance online publication, October 29, 2009; doi:10.1038/leu.2009.223
Letters to the Editor
Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
N Carbuccia, V Trouplin, V Gelsi-Boyer, A Murati, J Rocquain, J Adélaïde, S Olschwang, L Xerri, N Vey, M Chaffanet, D Birnbaum and M J Mozziconacci
Leukemia advance online publication, October 29, 2009; doi:10.1038/leu.2009.218
Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment
C Haferlach, U Bacher, S Schnittger, T Weiss, W Kern and T Haferlach
Leukemia advance online publication, October 29, 2009; doi:10.1038/leu.2009.222
Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells
M Kim, G J Madlambayan, M M Rahman, S E Smallwood, A M Meacham, K Hosaka, E W Scott, C R Cogle and G McFadden
Leukemia advance online publication, October 29, 2009; doi:10.1038/leu.2009.219
PML–RAR ligand-binding domain deletion mutations associated with reduced disease control and outcome after first relapse of APL
E Schachter-Tokarz, C Kelaidi, B Cassinat, C Chomienne, C Gardin, E Raffoux, H Dombret, P Fenaux and R Gallagher
Leukemia advance online publication, October 29, 2009; doi:10.1038/leu.2009.220
October 22 2009
Original Articles
The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status—clinical correlates in a study of 226 consecutive patients
A Pardanani, T L Lasho, C M Finke, N Gangat, A P Wolanskyj, C A Hanson and A Tefferi
Leukemia advance online publication, October 22, 2009; doi:10.1038/leu.2009.226
Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia
A Sanchez-Aguilera, I Rattmann, D Z Drew, L U W Müller, V Summey, D M Lucas, J C Byrd, C M Croce, Y Gu, J A Cancelas, P Johnston, T Moritz and D A Williams
Leukemia advance online publication, October 22, 2009; doi:10.1038/leu.2009.217
JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival
A Tefferi, T L Lasho, M M Patnaik, C M Finke, K Hussein, W J Hogan, M A Elliott, M R Litzow, C A Hanson and A Pardanani
Leukemia advance online publication, October 22, 2009; doi:10.1038/leu.2009.225
Letters to the Editor
Aberrant telomere structure is characteristic of resistant chronic lymphocytic leukaemia cells
T Brugat, N Gault, I Baccelli, J Maës, A Roborel de Climens, F Nguyen-Khac, F Davi, H Merle-Béral, E Gilson, M Goodhardt and J Delic
Leukemia advance online publication, October 22, 2009; doi:10.1038/leu.2009.213
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin
P Chevallier, T Prebet, A Pigneux, M Hunault, J Delaunay, F Perry, L Lode, S Richebourg, O Blanchet, N Vey, N Ifrah, N Milpied, D Blaise, J-L Harousseau and M Mohty
Leukemia advance online publication, October 22, 2009; doi:10.1038/leu.2009.214
Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies
A Renneville, S Kaltenbach, E Clappier, S Collette, J-B Micol, B Nelken, P Lepelley, N Dastugue, Y Benoît, Y Bertrand, C Preudhomme and H Cavé
Leukemia advance online publication, October 22, 2009; doi:10.1038/leu.2009.221
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia
P Secchiero, M G di Iasio, E Melloni, R Voltan, C Celeghini, M Tiribelli, M Dal Bo, V Gattei and G Zauli
Leukemia advance online publication, October 22, 2009; doi:10.1038/leu.2009.215
October 15 2009
Original Articles
Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis
K Kojima, M Konopleva, T Tsao, M Andreeff, H Ishida, Y Shiotsu, L Jin, Y Tabe and H Nakakuma
Leukemia advance online publication, October 15, 2009; doi:10.1038/leu.2009.212
Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis
M C Lanasa, S D Allgood, A D Volkheimer, J P Gockerman, J F Whitesides, B K Goodman, J O Moore, J B Weinberg and M C Levesque
Leukemia advance online publication, October 15, 2009; doi:10.1038/leu.2009.192
Letters to the Editor
Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome
M C J Jongmans, R P Kuiper, C L Carmichael, E J Wilkins, N Dors, A Carmagnac, A Y N Schouten-van Meeteren, X Li, M Stankovic, E Kamping, H Bengtsson, E F P M Schoenmakers, A Geurts van Kessel, P M Hoogerbrugge, C N Hahn, P P Brons, H S Scott and N Hoogerbrugge
Leukemia advance online publication, October 15, 2009; doi:10.1038/leu.2009.210
Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia
P Y Jotta, M A Ganazza, A Silva, M B Viana, M J da Silva, L J G Zambaldi, J T Barata, S R Brandalise and J A Yunes
Leukemia advance online publication, October 15, 2009; doi:10.1038/leu.2009.209
October 8 2009
Original Article
The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair
P Maiso, E Colado, E M Ocio, M Garayoa, J Martín, P Atadja, A Pandiella and J F San-Miguel
Leukemia advance online publication, October 8, 2009; doi:10.1038/leu.2009.182
Letter to the Editor
Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia
C Shustik, A R Turner, P Desjardins, L Fernandez, S Rubin, L Larratt, A M V Duncan, D Rizi, A Sadura, L Shepherd, D Li, L Rassenti and T Kipps
Leukemia advance online publication, October 8, 2009; doi:10.1038/leu.2009.205
October 1 2009
Spotlight Reviews
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review FREE
R Fonseca, P L Bergsagel, J Drach, J Shaughnessy, N Gutierrez, K Stewart, G Morgan, B Van Ness, M Chesi, S Minvielle, A Neri, B Barlogie, W M Kuehl, P Liebisch, F Davies, S Chen-Kiang, B G M Durie, R Carrasco, Orhan Sezer, Tony Reiman, Linda Pilarski and H Avet-Loiseau
Leukemia advance online publication, October 1, 2009; doi:10.1038/leu.2009.174
Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history FREE
E Jabbour, A Hochhaus, J Cortes, P La Rosée and H M Kantarjian
Leukemia advance online publication, October 1, 2009; doi:10.1038/leu.2009.193
Original Articles
In vivo dynamics of human cord blood-derived CD34- SCID-repopulating cells using intra-bone marrow injection
T Kimura, Y Matsuoka, M Murakami, T Kimura, M Takahashi, T Nakamoto, K Yasuda, K Matsui, K Kobayashi, S Imai, H Asano, R Nakatsuka, Y Uemura, Y Sasaki and Y Sonoda
Leukemia advance online publication, October 1, 2009; doi:10.1038/leu.2009.206
Oligomerization inhibition, combined with allosteric inhibition, abrogates the transformation potential of T315I-positive BCR/ABL
A A Mian, C Oancea, Z Zhao, O G Ottmann and M Ruthardt
Leukemia advance online publication, October 1, 2009; doi:10.1038/leu.2009.194
Stem cell traits in long-term co-culture revealed by time-lapse imaging
Y Song, A Bahnson, N Hall, H Yu, H Shen, D Koebler, R Houck, Y Xie and T Cheng
Leukemia advance online publication, October 1, 2009; doi:10.1038/leu.2009.191
September 24 2009
Original Articles
EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization
S Goyama, E Nitta, T Yoshino, S Kako, N Watanabe-Okochi, M Shimabe, Y Imai, K Takahashi and M Kurokawa
Leukemia advance online publication, September 24, 2009; doi:10.1038/leu.2009.202
Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia
M Jawad, C Seedhouse, U Mony, M Grundy, N H Russell and M Pallis
Leukemia advance online publication, September 24, 2009; doi:10.1038/leu.2009.199
Letters to the Editor
PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy
C G Molteni, G te Kronnie, S Bicciato, T Villa, M Tartaglia, G Basso, A Biondi and G Cazzaniga
Leukemia advance online publication, September 24, 2009; doi:10.1038/leu.2009.200
Low or undetectable numbers of Philadelphia chromosome-positive leukemic stem cells (Ph+CD34+CD38neg) in chronic myeloid leukemia patients in complete cytogenetic remission after tyrosine kinase inhibitor therapy
S Mustjoki, P Rohon, K Rapakko, S Jalkanen, P Koskenvesa, T Lundán and K Porkka
Leukemia advance online publication, September 24, 2009; doi:10.1038/leu.2009.190
Successful treatment of molecular relapse in NPM1-positive AML using 5-azacytidine
M Wermke, C Thiede, A Kiani, G Ehninger, M Bornhäuser and U Platzbecker
Leukemia advance online publication, September 24, 2009; doi:10.1038/leu.2009.204
Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines
R A Wilcox, D X Sun, A Novak, A Dogan, S M Ansell and A L Feldman
Leukemia advance online publication, September 24, 2009; doi:10.1038/leu.2009.198
September 17 2009
Original Articles
A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence
N Darzentas, A Hadzidimitriou, F Murray, K Hatzi, P Josefsson, N Laoutaris, C Moreno, A Anagnostopoulos, J Jurlander, A Tsaftaris, N Chiorazzi, C Belessi, P Ghia, R Rosenquist, F Davi and K Stamatopoulos
Leukemia advance online publication, September 17, 2009; doi:10.1038/leu.2009.186
Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR–ABL1-positive acute lymphoblastic leukemia patients
I Iacobucci, A Lonetti, F Messa, A Ferrari, D Cilloni, S Soverini, F Paoloni, F Arruga, E Ottaviani, S Chiaretti, M Messina, M Vignetti, C Papayannidis, A Vitale, F Pane, P P Piccaluga, S Paolini, G Berton, A Baruzzi, G Saglio, M Baccarani, R Foà and G Martinelli
Leukemia advance online publication, September 17, 2009; doi:10.1038/leu.2009.197
Letters to the Editor
The function of the pleckstrin homology domain in BCR–ABL-mediated leukemogenesis
S Demehri, T O'Hare, C A Eide, C A Smith, J W Tyner, B J Druker and M W N Deininger
Leukemia advance online publication, September 17, 2009; doi:10.1038/leu.2009.196
TP53 mutations in myeloid malignancies are either homozygous or hemizygous due to copy number-neutral loss of heterozygosity or deletion of 17p
M Jasek, L P Gondek, N Bejanyan, R Tiu, J Huh, K S Theil, C O'Keefe, M A McDevitt and J P Maciejewski
Leukemia advance online publication, September 17, 2009; doi:10.1038/leu.2009.189
Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia
H Lapillonne, L Llopis, A Auvrignon, A Renneville, M Labopin, F Mazingue, C Perot, J-L Lai, N Philippe, P Ballerini, V Zurawski, M Adam, L Douay, G Leverger, J Landman-Parker and C Preudhomme
Leukemia advance online publication, September 17, 2009; doi:10.1038/leu.2009.172
A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia
D E Spaner, Y Shi, D White, S Shaha, L He, A Masellis, K Wong and R Gorczynski
Leukemia advance online publication, September 17, 2009; doi:10.1038/leu.2009.195
September 10 2009
Spotlight Review
The use of novel agents in the treatment of relapsed and refractory multiple myeloma FREE
J P Laubach, A Mahindra, C S Mitsiades, R L Schlossman, N C Munshi, I M Ghobrial, N Carreau, T Hideshima, K C Anderson and P G Richardson
Leukemia advance online publication, September 10, 2009; doi:10.1038/leu.2009.179
Original Articles
The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53
E Drakos, V Atsaves, E Schlette, J Li, I Papanastasi, G Z Rassidakis and L J Medeiros
Leukemia advance online publication, September 10, 2009; doi:10.1038/leu.2009.180
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
N Hijiya, P Gaynon, E Barry, L Silverman, B Thomson, R Chu, T Cooper, R Kadota, M Rytting, P Steinherz, V Shen, S Jeha, R Abichandani and W L Carroll
Leukemia advance online publication, September 10, 2009; doi:10.1038/leu.2009.185
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG
E Lengfelder, C Haferlach, S Saussele, T Haferlach, B Schultheis, S Schnittger, W-D Ludwig, P Staib, C Aul, A Grüneisen, W Kern, A Reichle, H Serve, W E Berdel, J Braess, K Spiekermann, B Wörmann, M-C Sauerland, A Heinecke, W Hiddemann, R Hehlmann and T Büchner for the German AML Cooperative Group (AMLCG)
Leukemia advance online publication, September 10, 2009; doi:10.1038/leu.2009.183
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution
F P S Santos, S Faderl, G Garcia-Manero, C Koller, M Beran, S O'Brien, S Pierce, E J Freireich, X Huang, G Borthakur, C Bueso-Ramos, M de Lima, M Keating, J Cortes, H Kantarjian and F Ravandi
Leukemia advance online publication, September 10, 2009; doi:10.1038/leu.2009.181
Letters to the Editor
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients
R Gunnarsson, A Isaksson, M Mansouri, H Göransson, M Jansson, N Cahill, M Rasmussen, J Staaf, J Lundin, S Norin, A M Buhl, K E Smedby, H Hjalgrim, K Karlsson, J Jurlander, G Juliusson and R Rosenquist
Leukemia advance online publication, September 10, 2009; doi:10.1038/leu.2009.187
Identification of native, immunogenic peptides from Cyclin D1
M S von Bergwelt-Baildon, A Shimabukuro-Vornhagen, C M Wendtner and E Kondo
Leukemia advance online publication, September 10, 2009; doi:10.1038/leu.2009.184
September 3 2009
Review
Contribution of bone microenvironment to leukemogenesis and leukemia progression
F Ayala, R Dewar, M Kieran and R Kalluri
Leukemia advance online publication, September 3, 2009; doi:10.1038/leu.2009.175
Letter to the Editor
Cranial irradiation does not result in pituitary–gonadal axis dysfunction in very long-term male survivors of childhood acute lymphoblastic leukemia
N J van Casteren, R Pieters, G R Dohle, M van Baalen, S Neggers and M M van den Heuvel-Eibrink
Leukemia advance online publication, September 3, 2009; doi:10.1038/leu.2009.165
August 27 2009
Leading Article
Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation
R Ono, H Kumagai, H Nakajima, A Hishiya, T Taki, K Horikawa, K Takatsu, T Satoh, Y Hayashi, T Kitamura and T Nosaka
Leukemia advance online publication, August 27, 2009; doi:10.1038/leu.2009.177
Original Article
Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis
B Stamatopoulos, N Meuleman, C De Bruyn, P Mineur, P Martiat, D Bron and L Lagneaux
Leukemia advance online publication, August 27, 2009; doi:10.1038/leu.2009.176
Letters to the Editor
Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias
L Couronné, E Lippert, J Andrieux, O Kosmider, I Radford-Weiss, D Penther, N Dastugue, F Mugneret, M Lafage, N Gachard, N Nadal, O A Bernard and F Nguyen-Khac on behalf of the Groupe Francophone de Cytogénétique Hématologique
Leukemia advance online publication, August 27, 2009; doi:10.1038/leu.2009.169
Characterizing chromosomal break points of t(12;21)[ETV6–RUNX1]-positive leukaemia using multiple tiling PCR on whole-genome-amplified DNA
U Lausten-Thomsen, H O Madsen and K Schmiegelow
Leukemia advance online publication, August 27, 2009; doi:10.1038/leu.2009.170
Identification of a novel TEL–Lyn fusion gene in primary myelofibrosis
H Tanaka, M Takeuchi, Y Takeda, S Sakai, D Abe, C Ohwada, E Sakaida, N Shimizu, Y Saito, S Miyagi, A Iwama and C Nakaseko
Leukemia advance online publication, August 27, 2009; doi:10.1038/leu.2009.167
August 13 2009
Letter to the Editor
Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells
C Nishioka, T Ikezoe, J Yang and A Yokoyama
Leukemia advance online publication, August 13, 2009; doi:10.1038/leu.2009.163
August 6 2009
Letters to the Editor
Allergy and the risk of childhood leukemia: a meta-analysis
S Dahl, L S Schmidt, T Vestergaard, J Schüz and K Schmiegelow
Leukemia advance online publication, August 6, 2009; doi:10.1038/leu.2009.162
